Biogen (BIIB) Total Liabilities (2009 - 2026)

Biogen's Total Liabilities history runs 18 years deep, the most recent figure standing at $10.8 billion for Q1 2026.

• In Q1 2026, Total Liabilities fell 2.02% year-over-year to $10.8 billion; the TTM figure through Mar 2026 stood at $10.8 billion (down 2.02% YoY), while the FY2025 annual figure was $11.2 billion, down 1.33% from the prior year.
• Total Liabilities was $10.8 billion for Q1 2026 at Biogen, down from $11.2 billion in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $13.7 billion in Q3 2023 to a low of $10.7 billion in Q2 2025.
• Historically, Total Liabilities has averaged $11.6 billion across 5 years, with a median of $11.2 billion in 2025.
• Biggest YoY gain for Total Liabilities was 13.45% in 2023; the steepest drop was 19.08% in 2023.
• A 5-year view of Total Liabilities shows it stood at $11.2 billion in 2022, then advanced by 7.88% to $12.0 billion in 2023, then fell by 5.91% to $11.3 billion in 2024, then dropped by 1.33% to $11.2 billion in 2025, then fell by 3.14% to $10.8 billion in 2026.
• The last three Total Liabilities figures came in at $10.8 billion (Q1 2026), $11.2 billion (Q4 2025), and $11.0 billion (Q3 2025), per Business Quant data.